Current research on the immunomodulatory effect of allogeneic blood transfusion
- PMID: 9123921
- DOI: 10.1111/j.1423-0410.1996.tb01324.x
Current research on the immunomodulatory effect of allogeneic blood transfusion
Abstract
This review summarizes three aspects of current research on the immunomodulatory effect of allogeneic transfusion. Representatives of three laboratories-each of which is actively engaged in research on transfusion-induced immunomodulation-summarize their current investigative approach. First, current animal models of transfusion-induced immunomodulation are presented and research on the tumor growth-promoting effect of allogeneic transfusion is described. Second, mechanisms underlying an immunomodulatory effect of transfusion are summarized and experiments on the induction of transplant tolerance by selective introduction of donor-type MHC antigens is presented. Third, the potential clinical impact of increased infection and tumor recurrence resulting from transfusion-induced immunomodulation is assessed. The potential role of donor-derived hematopoietic stem cells is presented as an area of future investigation in the area of transfusion-induced immunomodulation.
Similar articles
-
Semi-allogeneic (F1) versus fully allogeneic blood transfusions: differences in their ability to induce specific immunological unresponsiveness.Eur J Immunol. 1996 Jul;26(7):1468-74. doi: 10.1002/eji.1830260710. Eur J Immunol. 1996. PMID: 8766548
-
Immunomodulatory effects of allogeneic blood transfusions: clinical manifestations and mechanisms.Vox Sang. 1998;74 Suppl 2:315-9. doi: 10.1111/j.1423-0410.1998.tb05437.x. Vox Sang. 1998. PMID: 9704462 Review.
-
Transfusion-related immunomodulation due to peripheral blood dendritic cells expressing the CD200 tolerance signaling molecule and alloantigen.Transfusion. 2008 May;48(5):814-21. doi: 10.1111/j.1537-2995.2008.01654.x. Epub 2008 Feb 21. Transfusion. 2008. PMID: 18298594
-
Induction of donor-specific T cell anergy by portal venous injection of allogeneic cells.Immunobiology. 1997 Nov;197(5):460-77. doi: 10.1016/S0171-2985(97)80079-4. Immunobiology. 1997. PMID: 9413746
-
Transfusion-induced immunomodulation and its clinical consequences.Transfus Med Rev. 1990 Oct;4(4 Suppl 1):24-35. doi: 10.1016/s0887-7963(90)70239-8. Transfus Med Rev. 1990. PMID: 2134638 Review.
Cited by
-
Identification of predictive factors for perioperative blood transfusion in colorectal resection patients.Int J Colorectal Dis. 2007 Dec;22(12):1493-7. doi: 10.1007/s00384-007-0347-2. Epub 2007 Sep 4. Int J Colorectal Dis. 2007. PMID: 17768632
-
Proposed mechanisms of transfusion-induced immunomodulation.Clin Diagn Lab Immunol. 1999 Sep;6(5):652-7. doi: 10.1128/CDLI.6.5.652-657.1999. Clin Diagn Lab Immunol. 1999. PMID: 10473511 Free PMC article. Review. No abstract available.
-
The efficiency and safety of intravenous tranexamic acid administration in open reduction and internal fixation of pelvic and acetabular fractures.Eur J Trauma Emerg Surg. 2022 Feb;48(1):351-356. doi: 10.1007/s00068-021-01624-0. Epub 2021 Feb 27. Eur J Trauma Emerg Surg. 2022. PMID: 33641043
-
Outcome analysis of blood product transfusion in trauma patients: a prospective, risk-adjusted study.World J Surg. 2008 Oct;32(10):2185-9. doi: 10.1007/s00268-008-9655-0. World J Surg. 2008. PMID: 18575931
-
A prophylactic TXA administration effectively reduces the risk of intraoperative bleeding during open management of pelvic and acetabular fractures.Sci Rep. 2023 Aug 2;13(1):12570. doi: 10.1038/s41598-023-39873-1. Sci Rep. 2023. PMID: 37532829 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials